Evidence map›Paper›PMID 30807449›Full record

Observational studyMedical care2019

Regional and Rural-Urban Differences in the Use of Direct-acting Antiviral Agents for Hepatitis C Virus: The Veteran Birth Cohort.

Basile Njei, Denise Esserman, Supriya Krishnan, Michael Ohl, Janet P Tate, Ronald G Hauser, Tamar Taddei, Joseph Lim, Amy C Justice

Abstract readObservational Study
In one paragraph

Observational study in Medical care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Trends in candidate hepatitis C virus nucleic acid amplification test (NAT)+ listing and associated impacts on liver transplantation waitlist outcomes.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Regional differences in access to direct-acting antiviral treatments for hepatitis C across Ontario: A cross-sectional study.Canada communicable disease report = Releve des maladies transmissibles au Canada · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Can Telementoring Reduce Urban-Rural Disparities in Utilization of Direct-Acting Antiviral Agents?Telemedicine journal and e-health : the official journal of the American Telemedicine Association · 2021
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Deaths Associated With Hepatitis C Virus Infection Among Residents in 50 States and the District of Columbia, 2016-2017.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Basile NjeiDepartment of Gastroenterology and Hepatology, Yale University School of Medicine.
Denise EssermanDepartment of Biostatistics, Yale University School of Public Health, VA Connecticut Healthcare System, New Haven.
Supriya KrishnanDepartment of Internal Medicine, Yale University School of Medicine, VA Connecticut Healthcare System, West Haven, CT.
Michael OhlVeterans Rural Health Resource Iowa City VA Medical Center, University of Iowa Carver College of Medicine, Iowa City, IA.
Janet P TateDepartment of Internal Medicine, Yale University School of Medicine, VA Connecticut Healthcare System, West Haven, CT.
Ronald G HauserCenter for Biomedical Data Science, Yale University School of Medicine, VA Connecticut Healthcare System.
Tamar TaddeiSection of Digestive Diseases, Department of Internal Medicine, Yale University School of Medicine, VA Connecticut Healthcare System, West Haven.
Joseph LimDepartment of Internal Medicine, Yale University School of Medicine, VA Connecticut Healthcare System, New Haven.
Amy C JusticeYale University School of Medicine, VA Connecticut Healthcare System, West Haven, CT.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Alcohol Associated Outcomes Among HIV+/- Aging VeteransU10AA013566 · NIAAA · YALE UNIVERSITY · PI JUSTICE, AMY CAROLINE · 2006 to 2010
$12.7M
Alcohol Associated Outcomes Among HIV+/-Aging VeteransU01AA013566 · NIAAA · YALE UNIVERSITY · PI JUSTICE, AMY CAROLINE · 2002 to 2005
$10.1M
Alcohol and Multisubstance Use in the Veterans Aging Cohort StudyU01AA020790 · NIAAA · YALE UNIVERSITY · PI JUSTICE, AMY CAROLINE · 2011 to 2020
$7.7M
Sex Disparities in Overall Response to ART Among HIV Infected IndividualsU24AA020794 · NIAAA · YALE UNIVERSITY · PI JUSTICE, AMY CAROLINE · 2011 to 2020
$5.5M
3/3 COMpAAAS Tripartite: ART-CC, KP, and VAU01AA026224 · NIAAA · YALE UNIVERSITY · PI JUSTICE, AMY CAROLINE · 2017 to 2021
$2.9M
Alcohol Associated Outcomes Among HIV+/-Aging VeteransR01AA013566 · NIAAA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JUSTICE, AMY CAROLINE · 2001 to 2002
$1.6M
Genetic Vulnerability for Sustained Multi-Substance Use in MVPI01BX003341 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI FEDERMAN, DANIEL, JUSTICE, AMY CAROLINE · 2017 to 2017
–
BLRD VA I01 BX003341Intramural VA VA999999NCATS NIH HHS UL1 TR001863NIAAA NIH HHS R01 AA013566NIAAA NIH HHS U01 AA013566NIAAA NIH HHS U01 AA020790NIAAA NIH HHS U01 AA026224NIAAA NIH HHS U10 AA013566NIAAA NIH HHS U24 AA020794
6 · The paper itself

Abstract

backgroundVeterans with hepatitis C virus (HCV) infection may face geographic obstacles to obtaining treatment.

objectiveWe studied the influence of region and rural versus urban residence on receipt of direct-acting antiretroviral (DAA) medications for HCV. SUBJECTS: Veterans receiving care within Veterans Affairs Healthcare System born between 1945 and 1965. RESEARCH

designThis is a observational study using national electronic health record data. MEASURES: Receipt of DAAs was defined as ≥1 filled prescription from January 1, 2014 to December 31, 2016. Region (South, Northeast, Midwest, and West) and residence (urban, rural-micropolitan, small rural towns, and isolated rural towns) variables were created using residential zone improvement plan codes and rural-urban commuting area (RUCA) codes. Multivariable models were adjusted for age, race, sex, severity of liver disease, comorbidities, and prior treatment experience.

resultsAmong 166,353 eligible patients 64,854 received, DAAs. Variation by rural-urban residence depended on region. In unadjusted analyses, receipt varied by rural-urban designations within Midwest, and West regions (P<0.05) but did not vary within the South (P=0.12). Southern rural small town had the lowest incidence of DAA receipt (40.1%), whereas the incidence was 52.9% in Midwestern isolated rural towns. In adjusted logistic analyses, compared with southern urban residents (the largest single group), southern rural small town residents had the lowest odds ratio, 0.85 (95% confidence interval, 0.75-0.93), and Midwestern residents from isolated and small rural towns had the highest odds (odds ratio, both 1.27) to receive treatment.

conclusionsSubstantial geographic variation exists in receipt of curative HCV treatment. Efforts are needed to provide more equitable access to DAAs.

Indexed as

AgedAntiviral AgentsFemaleHepacivirusHepatitis CHumansMaleRural PopulationUnited StatesUnited States Department of Veterans AffairsUrban PopulationVeteransAntiviral Agents

Identifiers

PMID30807449
PMCPMC6436819

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.